Position in SNDX
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$123,202
-$8,869,767 QoQ
Shares Held
5,636
-98.5% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#187
of 242 holders
Holding Since
Dec 2022
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SNDX Over Time
Shares Held
Position Value (USD)
Derivatives in SNDX
reported options exposure · as of Jun 30, 2026CallValue
$139,904
CallShares
6,400
PutValue
$10,930
PutShares
500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Walleye Capital LLC holds $328,656,270 across 126 Biotechnology names. SNDX ranks #101 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
126,005 | $33,608,053 | |
| 2 | CYTK |
Cytokinetics Inc
|
239,728 | $20,422,428 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
288,233 | $16,492,692 | |
| 4 | IDYA |
IDEAYA Biosciences, Inc.
|
386,183 | $14,393,040 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
22,596 | $14,089,509 | |
| 6 | RARE |
Ultragenyx Pharmaceutical Inc.
|
334,854 | $11,180,775 | |
| 7 | TYRA |
Tyra Biosciences, Inc.
|
347,898 | $11,111,862 | |
| 8 | BCAX |
Bicara Therapeutics Inc.
|
353,226 | $10,487,279 |
All Filings in SNDX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $139,904 | 6,400 | Call | Sole | 2026-08-03 | |
| 2026-06-30 | $10,930 | 500 | Put | Sole | 2026-08-03 | |
| 2026-06-30 | $123,202 | 5,636 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $126,144 | 5,400 | Call | Sole | 2026-05-13 | |
| 2026-03-31 | $8,992,969 | 384,973 | Shares | Sole | 2026-05-13 | |
| 2026-03-31 | $273,312 | 11,700 | Put | Sole | 2026-05-13 | |
| 2025-12-31 | $292,039 | 13,900 | Put | Sole | 2026-02-13 | |
| 2025-12-31 | $287,837 | 13,700 | Call | Sole | 2026-02-13 | |
| 2025-12-31 | $508,547 | 24,205 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $289,238 | 18,800 | Call | Sole | 2025-11-14 | |
| 2025-09-30 | $341,547 | 22,200 | Put | Sole | 2025-11-14 | |
| 2025-09-30 | $4,579,468 | 297,658 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $267,839 | 28,600 | Put | Sole | 2025-08-13 | |
| 2025-06-30 | $2,116,630 | 226,015 | Shares | Sole | 2025-08-13 | |
| 2025-06-30 | $277,204 | 29,600 | Call | Sole | 2025-08-13 | |
| 2025-03-31 | $4,018,841 | 327,134 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $4,821,995 | 364,750 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $734,676 | 38,165 | Shares | Sole | 2024-11-14 | |
| 2024-09-30 | $19,250 | 1,000 | Call | Sole | 2024-11-14 | |
| 2023-12-31 | $140,465 | 6,500 | Put | Sole | 2024-02-14 | |
| 2023-12-31 | $2,764,610 | 127,932 | Shares | Sole | 2024-02-14 | |
| 2023-12-31 | $88,601 | 4,100 | Call | Sole | 2024-02-14 | |
| 2023-06-30 | $5,535,231 | 264,464 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $11,512,300 | 545,090 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $8,437,972 | 331,551 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||